Toll-like receptor 2-mediated MAPKs and NF-κB activation requires the GNAO1-dependent pathway in human mast cells

Meiling Jin1, Bo Yu, Weizhen Zhang

  • 1Center for Diabetes, Obesity and Metabolism, Department of Physiology, Shenzhen University Health Science Center, Shenzhen, Guangdong province 518060, China. echoyyyu@163.com.

Insights

Toll-like receptor 2 (TLR2) activation on human mast cells triggers inflammatory mediator release. This process involves specific signaling pathways, including Go proteins, crucial for IL-8 release.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Toll-like receptors (TLRs) on mast cells are vital for pathogen defense.
  • Previous research indicated TLR2 agonists Pam3CSK4 and PGN stimulate IL-8 release in human mast cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying TLR2-mediated IL-8 release in human mast cells.
  • To investigate the role of heterotrimeric G proteins in TLR2 signaling.

Main Methods:

  • Utilized the human mast cell line LAD2.
  • Employed TLR2 shRNA to confirm TLR2 mediation.
  • Analyzed the activation of MAPKs, NF-κB, PI3K-Akt, and Ca(2+)-calcineurin-NFAT signaling pathways.
  • Assessed the impact of Go protein depletion on IL-8 release.

Main Results:

  • Pam3CSK4-induced IL-8 release was confirmed as TLR2-mediated.
  • Pam3CSK4 activated multiple signaling cascades, including MAPKs, NF-κB, PI3K-Akt, and Ca(2+)-calcineurin-NFAT.
  • Go proteins were essential for MAPK and NF-κB activation in TLR2-stimulated LAD2 cells.
  • Depletion of Go proteins reduced IL-8 release.

Conclusions:

  • TLR2 activation in human mast cells initiates inflammatory mediator release through distinct signaling pathways.
  • Go proteins play a partial but significant role in TLR2-mediated IL-8 release from mast cells.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
9.3K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.4K
Inflammation01:38

Inflammation

Overview
63.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K